Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Maserati, E; Aprili, F; Vinante, F; Locatelli, F; Amendola, G; Zatterale, A; Milone, G; Minelli, A; Bernardi, F; Lo Curto, F; Pasquali, F
   Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20%of cases
   GENES CHROMOSOMES & CANCER
   
   E. Maserati et al., "Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20%of cases", GENE CHROM, 33(1), 2002, pp. 93-97
2. Mazzoran, L; Zorat, F; Chemello, L; Croce, LS; Rigato, I; Cavalletto, L; Bernardinello, E; Tiribelli, C; Alberti, A; Pozzato, G
   Human leucocyte interferon-alpha in the treatment of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   L. Mazzoran et al., "Human leucocyte interferon-alpha in the treatment of chronic hepatitis C", DIG LIVER D, 33(4), 2001, pp. 347-352
3. Capra, F; De Maria, E; Franchini, M; Gandini, G
   Effective antiviral treatment for hepatitis C virus-related chronic activehepatitis in haemophiliac patients
   DIGESTIVE AND LIVER DISEASE
   
   F. Capra et al., "Effective antiviral treatment for hepatitis C virus-related chronic activehepatitis in haemophiliac patients", DIG LIVER D, 33(4), 2001, pp. 389-389
4. Morisco, F; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; Del Buono, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, N; Carella, C
   Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   F. Morisco et al., "Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C", DIG LIVER D, 33(3), 2001, pp. 247-253
5. Sartori, M; Andorno, S; Rigamonti, C; Boldorini, R
   Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome
   DIGESTIVE AND LIVER DISEASE
   
   M. Sartori et al., "Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome", DIG LIVER D, 33(2), 2001, pp. 157-162
6. Barbaro, G; Di Lorenzo, G; Belloni, G; Asti, A; Pellicelli, AM; Barbarini, G
   Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype
   DIGESTIVE AND LIVER DISEASE
   
   G. Barbaro et al., "Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype", DIG LIVER D, 33(1), 2001, pp. 81-83
7. Asselin-Paturel, C; Boonstra, A; Dalod, M; Durand, I; Yessaad, N; Dezutter-Dambuyant, C; Vicari, A; O'Garra, A; Biron, C; Briere, F; Trinchieri, G
   Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology
   NATURE IMMUNOLOGY
   
   C. Asselin-Paturel et al., "Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology", NAT IMMUNOL, 2(12), 2001, pp. 1144-1150
8. Howell, SB
   Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology
   CANCER JOURNAL
   
   S.B. Howell, "Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology", CANCER J, 7(3), 2001, pp. 219-227
9. Sondak, VK
   Adjuvant therapy for melanoma
   CANCER JOURNAL
   
   V.K. Sondak, "Adjuvant therapy for melanoma", CANCER J, 7, 2001, pp. S24-S27
10. Rosen, HR
    Hepatitis B and C in the liver transplant recipient: Current understandingand treatment
    LIVER TRANSPLANTATION
    
    H.R. Rosen, "Hepatitis B and C in the liver transplant recipient: Current understandingand treatment", LIVER TRANS, 7(11), 2001, pp. S87-S98
11. Muller, L; Provenzani, C; Pawelec, G
    Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures
    JOURNAL OF IMMUNOTHERAPY
    
    L. Muller et al., "Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures", J IMMUNOTH, 24(6), 2001, pp. 482-492
12. Sconocchia, G; Cococcetta, NY; Campagnano, L; Amadori, S; Iorio, B; Boffo, V; Ferdinandi, V; Del Principe, I; Adorno, D; Casciani, CU
    Subcutaneous administration of interleukin-2 triggers Fc gamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies
    JOURNAL OF IMMUNOTHERAPY
    
    G. Sconocchia et al., "Subcutaneous administration of interleukin-2 triggers Fc gamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies", J IMMUNOTH, 24(4), 2001, pp. 374-383
13. Koie, T; Suzuki, K; Shimoyama, T; Umeda, T; Nakaji, S; Sugawara, K
    Effect of interferon-alpha on production of reactive oxygen species by human neutrophils
    LUMINESCENCE
    
    T. Koie et al., "Effect of interferon-alpha on production of reactive oxygen species by human neutrophils", LUMINESCENC, 16(1), 2001, pp. 39-43
14. Levine, SM; Stone, JH
    New approaches to treatment in systemic vasculitis: biological therapies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    S.M. Levine e J.H. Stone, "New approaches to treatment in systemic vasculitis: biological therapies", BEST PR R C, 15(2), 2001, pp. 315-333
15. Stern, PL; Faulkner, R; Veranes, EC; Davidson, EJ
    The role of human papillomavirus vaccines in cervical neoplasia
    BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    
    P.L. Stern et al., "The role of human papillomavirus vaccines in cervical neoplasia", BEST P R CL, 15(5), 2001, pp. 783-799
16. Chase, A; Huntly, BJP; Cross, NCP
    Cytogenetics of chronic myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    A. Chase et al., "Cytogenetics of chronic myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 553-571
17. Chapel, HM; Christie, JML; Peach, V; Chapman, RWG
    Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C
    CLINICAL IMMUNOLOGY
    
    H.M. Chapel et al., "Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C", CLIN IMMUNO, 99(3), 2001, pp. 320-324
18. Feldman, S; Stein, D; Amrute, S; Denny, T; Garcia, Z; Kloser, P; Sun, Y; Megjugorac, N; Fitzgerald-Bocarsly, P
    Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors
    CLINICAL IMMUNOLOGY
    
    S. Feldman et al., "Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors", CLIN IMMUNO, 101(2), 2001, pp. 201-210
19. Demmers, KJ; Derecka, K; Flint, A
    Trophoblast interferon and pregnancy
    REPRODUCTION
    
    K.J. Demmers et al., "Trophoblast interferon and pregnancy", REPRODUCT, 121(1), 2001, pp. 41-49
20. Brake, M; Loertzer, H; Horsch, R; Keller, H
    Treatment of Peyronie's disease with local interferon-alpha 2b
    BJU INTERNATIONAL
    
    M. Brake et al., "Treatment of Peyronie's disease with local interferon-alpha 2b", BJU INT, 87(7), 2001, pp. 654-657
21. Jowett, SL; Agarwal, K; Smith, BC; Craig, W; Hewett, M; Bassendine, DR; Gilvarry, E; Burt, AD; Basendine, MF
    Managing chronic hepatitis C acquired through intravenous drug use
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    S.L. Jowett et al., "Managing chronic hepatitis C acquired through intravenous drug use", QJM-MON J A, 94(3), 2001, pp. 153-158
22. Sasadeusz, J
    Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones
    INTERNAL MEDICINE JOURNAL
    
    J. Sasadeusz, "Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones", INTERN M J, 31(7), 2001, pp. 418-421
23. Moradpour, D; Cerny, A; Heim, MH; Blum, HE
    Hepatitis C: an update
    SWISS MEDICAL WEEKLY
    
    D. Moradpour et al., "Hepatitis C: an update", SWISS MED W, 131(21-22), 2001, pp. 291-298
24. Cristofanilli, M; Pescosolido, N; Risuleo, G; Scarsella, G
    A murine cell culture model for post-trabeculectomy anfibrotic treatment: Induction of apoptosis by Cyclosporin
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    M. Cristofanilli et al., "A murine cell culture model for post-trabeculectomy anfibrotic treatment: Induction of apoptosis by Cyclosporin", ACT OPHTH S, 79(3), 2001, pp. 309-312
25. Arens, M
    Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV
    JOURNAL OF CLINICAL VIROLOGY
    
    M. Arens, "Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV", J CLIN VIRO, 22(1), 2001, pp. 11-29
26. Schinkel, J; Kroes, ACM; Wagtmans, MJ; Lamers, CBHW; van Hoek, B
    Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays
    JOURNAL OF CLINICAL VIROLOGY
    
    J. Schinkel et al., "Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays", J CLIN VIRO, 22(1), 2001, pp. 61-71
27. Jorgensen, PA; Neuwald, PD
    Standardized hepatitis C virus RNA panels for nucleic acid testing assays
    JOURNAL OF CLINICAL VIROLOGY
    
    P.A. Jorgensen e P.D. Neuwald, "Standardized hepatitis C virus RNA panels for nucleic acid testing assays", J CLIN VIRO, 20(1-2), 2001, pp. 35-40
28. Grahovac, B; Bingulac-Popovic, J; Vucelic, B; Hrstic, I; Ostojic, R; Drazic, V; Balija, M; Grgicevic, D
    Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C
    JOURNAL OF CLINICAL VIROLOGY
    
    B. Grahovac et al., "Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C", J CLIN VIRO, 20(1-2), 2001, pp. 85-89
29. Suou, T; Mitsuda, A; Koda, M; Matsuda, H; Maruyama, S; Tanaka, H; Kishimoto, Y; Michimori, K; Hirooka, Y; Kawasaki, H
    Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study
    HEPATOLOGY RESEARCH
    
    T. Suou et al., "Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study", HEPATOL RES, 20(3), 2001, pp. 301-311
30. Arase, Y; Ikeda, K; Chayama, K; Murashima, N; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Kobayashi, M; Suzuki, F; Kumada, H
    Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
    HEPATOLOGY RESEARCH
    
    Y. Arase et al., "Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration", HEPATOL RES, 19(1), 2001, pp. 22-30
31. Lao, YH
    Endogenous angiogenesis inhibitors and their therapeutic implications
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    
    Y.H. Lao, "Endogenous angiogenesis inhibitors and their therapeutic implications", INT J BIO C, 33(4), 2001, pp. 357-369
32. Jelic, S; Babovic, N; Stamatovic, L; Kreacic, M; Matkovic, S; Popov, I
    Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study
    MEDICAL ONCOLOGY
    
    S. Jelic et al., "Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study", MED ONCOL, 18(3), 2001, pp. 189-195
33. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
    Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials
    MEDICAL ONCOLOGY
    
    M.B. Atkins et al., "Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials", MED ONCOL, 18(3), 2001, pp. 197-207
34. Sangfelt, O; Strander, H
    Apoptosis and cell growth inhibition as antitumor effector functions of interferons
    MEDICAL ONCOLOGY
    
    O. Sangfelt e H. Strander, "Apoptosis and cell growth inhibition as antitumor effector functions of interferons", MED ONCOL, 18(1), 2001, pp. 3-14
35. Takeuchi, K; Komatsu, T; Yokoo, J; Kato, A; Shioda, T; Nagai, Y; Gotoh, B
    Sendai virus C protein physically associates with Stat1
    GENES TO CELLS
    
    K. Takeuchi et al., "Sendai virus C protein physically associates with Stat1", GENES CELLS, 6(6), 2001, pp. 545-557
36. Geschwind, MD; Skolasky, RI; Royal, WS; McArthur, JC
    The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS
    JOURNAL OF NEUROVIROLOGY
    
    M.D. Geschwind et al., "The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS", J NEUROVIRO, 7(4), 2001, pp. 353-357
37. Shieh, TM; Carter, DL; Blosser, RL; Mankowski, JL; Zink, MC; Clements, JE
    Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus
    JOURNAL OF NEUROVIROLOGY
    
    T.M. Shieh et al., "Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus", J NEUROVIRO, 7(1), 2001, pp. 11-24
38. Zein, NN
    Experimental and emerging therapies for chronic hepatitis C virus infection
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    N.N. Zein, "Experimental and emerging therapies for chronic hepatitis C virus infection", EXPERT OP I, 10(8), 2001, pp. 1457-1469
39. Merle, P; Trepo, C
    Therapeutic management of hepatitis B-related cirrhosis
    JOURNAL OF VIRAL HEPATITIS
    
    P. Merle e C. Trepo, "Therapeutic management of hepatitis B-related cirrhosis", J VIRAL HEP, 8(6), 2001, pp. 391-399
40. Kanzler, S; Baumann, M; Schirmacher, P; Dries, V; Bayer, E; Gerken, G; Dienes, HP; Lohse, AW
    Prediction of progressive liver fibrosis in hepatitis C infection by serumand tissue levels of transforming growth factor-beta
    JOURNAL OF VIRAL HEPATITIS
    
    S. Kanzler et al., "Prediction of progressive liver fibrosis in hepatitis C infection by serumand tissue levels of transforming growth factor-beta", J VIRAL HEP, 8(6), 2001, pp. 430-437
41. Lin, CC; Wu, JC; Chang, TT; Huang, YH; Wang, YJ; Tsay, SH; Chow, NH; Chang, FY; Lee, SD
    Long-term evaluation of recombinant interferon alpha 2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan
    JOURNAL OF VIRAL HEPATITIS
    
    C.C. Lin et al., "Long-term evaluation of recombinant interferon alpha 2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan", J VIRAL HEP, 8(6), 2001, pp. 438-446
42. Papatheodoridis, GV; Hadziyannis, SJ
    Diagnosis and management of pre-core mutant chronic hepatitis B
    JOURNAL OF VIRAL HEPATITIS
    
    G.V. Papatheodoridis e S.J. Hadziyannis, "Diagnosis and management of pre-core mutant chronic hepatitis B", J VIRAL HEP, 8(5), 2001, pp. 311-321
43. Lindh, M; Hannoun, C; Horal, P; Krogsgaard, K
    Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay
    JOURNAL OF VIRAL HEPATITIS
    
    M. Lindh et al., "Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay", J VIRAL HEP, 8(5), 2001, pp. 349-357
44. Shehab, TM; Sonnad, SS; Lok, ASF
    Management of hepatitis C patients by primary care physicians in the USA: results of a national survey
    JOURNAL OF VIRAL HEPATITIS
    
    T.M. Shehab et al., "Management of hepatitis C patients by primary care physicians in the USA: results of a national survey", J VIRAL HEP, 8(5), 2001, pp. 377-383
45. Teuber, G; Berg, T; Naumann, U; Raedle, J; Brinkmann, S; Hopf, U; Zeuzem, S
    Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    G. Teuber et al., "Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C", J VIRAL HEP, 8(4), 2001, pp. 276-283
46. Gaeta, GB; Stornaiuolo, G; Stanzione, M; Ascione, T; Pasquazzi, C; Taliani, G; Cimino, L; Budillon, G; Piccinino, F
    Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study
    JOURNAL OF VIRAL HEPATITIS
    
    G.B. Gaeta et al., "Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study", J VIRAL HEP, 8(4), 2001, pp. 284-286
47. Bruchfeld, A; Stahle, L; Andersson, J; Schvarcz, R
    Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study
    JOURNAL OF VIRAL HEPATITIS
    
    A. Bruchfeld et al., "Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study", J VIRAL HEP, 8(4), 2001, pp. 287-292
48. Teixeira, R; Papatheodoridis, GV; Burroughs, AK
    Management of recurrent hepatitis C after liver transplantation
    JOURNAL OF VIRAL HEPATITIS
    
    R. Teixeira et al., "Management of recurrent hepatitis C after liver transplantation", J VIRAL HEP, 8(3), 2001, pp. 159-168
49. Harcourt, G; Hellier, S; Bunce, M; Satsangi, J; Collier, J; Chapman, R; Phillips, R; Klenerman, P
    Effect of HLA class II genotype on T helper lymphocyte responses and viralcontrol in hepatitis C virus infection
    JOURNAL OF VIRAL HEPATITIS
    
    G. Harcourt et al., "Effect of HLA class II genotype on T helper lymphocyte responses and viralcontrol in hepatitis C virus infection", J VIRAL HEP, 8(3), 2001, pp. 174-179
50. Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M
    In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    P. Andreone et al., "In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C", J VIRAL HEP, 8(3), 2001, pp. 194-201
51. Larrea, E; Alberdi, A; Castelruiz, Y; Boya, P; Civeira, MP; Prieto, J
    Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha 5
    JOURNAL OF VIRAL HEPATITIS
    
    E. Larrea et al., "Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha 5", J VIRAL HEP, 8(2), 2001, pp. 103-110
52. Comanor, L; Minor, J; Conjeevaram, HS; Roberts, EA; Alvarez, F; Bern, EM; Goyens, P; Rosenthal, P; Lachaux, A; Shelton, M; Sarles, J; Sokal, EM
    Impact of chronic hepatitis B and interferon-alpha therapy on growth of children
    JOURNAL OF VIRAL HEPATITIS
    
    L. Comanor et al., "Impact of chronic hepatitis B and interferon-alpha therapy on growth of children", J VIRAL HEP, 8(2), 2001, pp. 139-147
53. Thevenot, T; Regimbeau, C; Ratziu, V; Leroy, V; Opolon, P; Poynard, T
    Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update
    JOURNAL OF VIRAL HEPATITIS
    
    T. Thevenot et al., "Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update", J VIRAL HEP, 8(1), 2001, pp. 48-62
54. Gursoy, M; Gur, G; Arslan, H; Ozdemir, N; Boyacioglu, S
    Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment
    JOURNAL OF VIRAL HEPATITIS
    
    M. Gursoy et al., "Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment", J VIRAL HEP, 8(1), 2001, pp. 70-77
55. Regina, S; Colombat, P; Fimbel, B; Guerois, C; Gruel, Y
    Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha
    HAEMOPHILIA
    
    S. Regina et al., "Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha", HAEMOPHILIA, 7(5), 2001, pp. 526-527
56. Aguilar, C; Lucia, JF; Simon, MA
    An emerging role for interferon in haemophiliacs with chronic hepatitis C?
    HAEMOPHILIA
    
    C. Aguilar et al., "An emerging role for interferon in haemophiliacs with chronic hepatitis C?", HAEMOPHILIA, 7(1), 2001, pp. 6-8
57. Bagnato, F; Pietropoaolo, V; Di Taranto, C; Lorenzano, S; Toni, D
    Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy withouth apparent immunodepression
    EUROPEAN JOURNAL OF NEUROLOGY
    
    F. Bagnato et al., "Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy withouth apparent immunodepression", EUR J NEUR, 8(4), 2001, pp. 367-368
58. Barber, GN
    Host defense, viruses and apoptosis
    CELL DEATH AND DIFFERENTIATION
    
    G.N. Barber, "Host defense, viruses and apoptosis", CELL DEAT D, 8(2), 2001, pp. 113-126
59. Nobile-Orazio, E; Carpo, M
    Neuropathy and monoclonal gammopathy
    CURRENT OPINION IN NEUROLOGY
    
    E. Nobile-Orazio e M. Carpo, "Neuropathy and monoclonal gammopathy", CURR OP NEU, 14(5), 2001, pp. 615-620
60. Zuckerman, E; Yeshurun, D; Rosner, I
    Management of hepatitis C virus-related arthritis
    BIODRUGS
    
    E. Zuckerman et al., "Management of hepatitis C virus-related arthritis", BIODRUGS, 15(9), 2001, pp. 573-584
61. van West, D; Maes, M
    Neuroendocrine and immune aspects of fibromyalgia
    BIODRUGS
    
    D. van West e M. Maes, "Neuroendocrine and immune aspects of fibromyalgia", BIODRUGS, 15(8), 2001, pp. 521-531
62. Russell, AI; Lawson, WA; Haskard, DO
    Potential new therapeutic options in Behcet's syndrome
    BIODRUGS
    
    A.I. Russell et al., "Potential new therapeutic options in Behcet's syndrome", BIODRUGS, 15(1), 2001, pp. 25-35
63. Batra, N
    Hepatitis C screening and treatment versus liver transplantation - A financial option appraisal and commissioning model for purchasers
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    N. Batra, "Hepatitis C screening and treatment versus liver transplantation - A financial option appraisal and commissioning model for purchasers", DIS MANAG H, 9(7), 2001, pp. 371-384
64. Chabannes, E; Bernardini, S; Wallerand, H; Bittard, H
    Angiogenesis in bladder tumours: prognostic indicator and therapeutic target.
    PROGRES EN UROLOGIE
    
    E. Chabannes et al., "Angiogenesis in bladder tumours: prognostic indicator and therapeutic target.", PROG UROL, 11(3), 2001, pp. 417-427
65. Perrella, O; Carrieri, PB; Perrella, A; Sbreglia, C; Gorga, F; Guarnaccia, D; Tarantino, G
    Transforming growth factor-beta1 and interferon-alpha in the AIDS dementiacomplex (ADC): possible relationship with cerebral viral load?
    EUROPEAN CYTOKINE NETWORK
    
    O. Perrella et al., "Transforming growth factor-beta1 and interferon-alpha in the AIDS dementiacomplex (ADC): possible relationship with cerebral viral load?", EUR CYTOKIN, 12(1), 2001, pp. 51-55
66. Saenz, MJ
    Treatment of chronic hepatitis C in refractory patients. What is the answer?
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    M.J. Saenz, "Treatment of chronic hepatitis C in refractory patients. What is the answer?", REV ESP E D, 93(6), 2001, pp. 350-352
67. Koretz, RL
    Hepatitis C - The case against treatment
    EUROPEAN JOURNAL OF SURGERY
    
    R.L. Koretz, "Hepatitis C - The case against treatment", EURO J SURG, 167, 2001, pp. 34-39
68. Edelstein, MA; Martin, P
    Chronic hepatitis C: Current status and rationale for antiviral therapy
    EUROPEAN JOURNAL OF SURGERY
    
    M.A. Edelstein e P. Martin, "Chronic hepatitis C: Current status and rationale for antiviral therapy", EURO J SURG, 167, 2001, pp. 49-55
69. Benthin, M; Dallmann, I; Atzpodien, J
    13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    M. Benthin et al., "13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro", CANC BIO R, 16(4), 2001, pp. 323-331
70. Darcissac, ECA; Vidal, V; Guillaume, M; Thebault, JJ; Bahr, GM
    Clinical tolerance and profile of cytokine induction in healthy volunteersfollowing the simultaneous administration of IFN-alpha and the synthetic immunomodulator murabutide
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    E.C.A. Darcissac et al., "Clinical tolerance and profile of cytokine induction in healthy volunteersfollowing the simultaneous administration of IFN-alpha and the synthetic immunomodulator murabutide", J INTERF CY, 21(9), 2001, pp. 655-661
71. Oczko-Grzesik, B; Wiecek, A; Kokot, F
    Influence of IFN-alpha on plasma erythropoietin levels in patients with hepatitis B virus-associated chronic active hepatitis
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    B. Oczko-Grzesik et al., "Influence of IFN-alpha on plasma erythropoietin levels in patients with hepatitis B virus-associated chronic active hepatitis", J INTERF CY, 21(9), 2001, pp. 669-676
72. Grossberg, SE; Kawade, Y; Kohase, M; Klein, JP
    The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: The tenfold reduction unit
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    S.E. Grossberg et al., "The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: The tenfold reduction unit", J INTERF CY, 21(9), 2001, pp. 743-755
73. Meritet, JF; Maury, C; Tovey, MG
    Effect of oromucosal administration of IFN-alpha on allergic sensitizationand the hypersensitive inflammatory response in animals sensitized to ragweed pollen
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    J.F. Meritet et al., "Effect of oromucosal administration of IFN-alpha on allergic sensitizationand the hypersensitive inflammatory response in animals sensitized to ragweed pollen", J INTERF CY, 21(8), 2001, pp. 583-593
74. Borgia, G; Reynaud, L; Gentile, I; Cerini, R; Ciampi, R; Dello Russo, M; Piazza, M
    Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    G. Borgia et al., "Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C", J INTERF CY, 21(7), 2001, pp. 469-470
75. Berg, K; Bolt, G; Andersen, H; Owen, TC
    Zinc potentiates the antiviral action of human IFN-alpha tenfold
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    K. Berg et al., "Zinc potentiates the antiviral action of human IFN-alpha tenfold", J INTERF CY, 21(7), 2001, pp. 471-474
76. Rath, PC; Aggarwal, BB
    Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    P.C. Rath e B.B. Aggarwal, "Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells", J INTERF CY, 21(7), 2001, pp. 523-528
77. Fornai, C; Maggi, F; Favilli, F; Vatteroni, ML; Pistello, M; Marchi, S; Ciccorossi, P; Antonelli, G; Bendinelli, M
    Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    C. Fornai et al., "Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients", J INTERF CY, 21(6), 2001, pp. 417-422
78. Curelli, S; Romerio, F; Mirandola, P; Barion, P; Bemis, K; Zella, D
    Human primary CD4(+) T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    S. Curelli et al., "Human primary CD4(+) T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase", J INTERF CY, 21(6), 2001, pp. 431-437
79. Malaguarnera, M; Laurino, A; Di Fazio, I; Pistone, G; Castorina, M; Guccione, N; Rampello, L
    Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    M. Malaguarnera et al., "Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C", J INTERF CY, 21(5), 2001, pp. 273-278
80. Tolo, H; Kauppinen, HL; Alm, G; Perers, A; Lindeberg, E; Wahlstedt-Froberg, V; Parkkinen, J
    Development of a highly purified multicomponent leukocyte IFN-alpha product
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    H. Tolo et al., "Development of a highly purified multicomponent leukocyte IFN-alpha product", J INTERF CY, 21(11), 2001, pp. 913-920
81. Hatzakis, A; Gargalianos, P; Kiosses, V; Lazanas, M; Sypsa, V; Anastassopoulou, C; Vigklis, V; Sambatakou, H; Botsi, C; Paraskevis, D; Stalgis, C
    Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    A. Hatzakis et al., "Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication", J INTERF CY, 21(10), 2001, pp. 861-869
82. Rapoport, AP; Simons-Evelyn, M; Chen, T; Sidell, R; Luhowskyj, S; Rosell, K; Obrig, T; Hicks, D; Hinkle, PM; Nahm, M; Insel, RA; Abboud, CN
    Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes
    BLOOD CELLS MOLECULES AND DISEASES
    
    A.P. Rapoport et al., "Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes", BL CELL M D, 27(3), 2001, pp. 610-624
83. Altucci, L; Rossin, A; Raffelsberger, W; Reitmair, A; Chomienne, C; Gronemeyer, H
    Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrineaction of tumor-selective death ligand TRAIL
    NATURE MEDICINE
    
    L. Altucci et al., "Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrineaction of tumor-selective death ligand TRAIL", NAT MED, 7(6), 2001, pp. 680-686
84. Biancone, L; Pavia, M; Blanco, GD; D'Inca, R; Castiglione, F; De Nigris, F; Doldo, P; Cosco, C; Vavassori, P; Bresci, GP; Arrigoni, A; Cadau, G; Monteleone, I; Rispo, A; Fries, W; Mallardi, B; Sturniolo, GC; Pallone, F
    Hepatitis B and C virus infection in Crohn's disease
    INFLAMMATORY BOWEL DISEASES
    
    L. Biancone et al., "Hepatitis B and C virus infection in Crohn's disease", INFLAMM B D, 7(4), 2001, pp. 287-294
85. Buzaid, AC; Atkins, M
    Practical guidelines for the management of biochemotherapy-related toxicity in melanoma
    CLINICAL CANCER RESEARCH
    
    A.C. Buzaid e M. Atkins, "Practical guidelines for the management of biochemotherapy-related toxicity in melanoma", CLIN CANC R, 7(9), 2001, pp. 2611-2619
86. Recchia, F; De Filippis, S; Rosselli, M; Saggio, G; Cesta, A; Fumagalli, L; Rea, S
    Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer
    CLINICAL CANCER RESEARCH
    
    F. Recchia et al., "Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer", CLIN CANC R, 7(5), 2001, pp. 1251-1257
87. Slingluff, CL; Yamshchikov, G; Neese, P; Galavotti, H; Eastham, S; Engelhard, VH; Kittlesen, D; Deacon, D; Hibbitts, S; Grosh, WW; Petroni, G; Cohen, R; Wiernasz, C; Patterson, JW; Conway, BP; Ross, WG
    Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: Immunologic and clinical outcomes
    CLINICAL CANCER RESEARCH
    
    C.L. Slingluff et al., "Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: Immunologic and clinical outcomes", CLIN CANC R, 7(10), 2001, pp. 3012-3024
88. Strickland, DK; Jenkins, JJ; Hudson, MM
    Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    D.K. Strickland et al., "Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer", J PED H ONC, 23(8), 2001, pp. 527-529
89. Suryanarayan, K; Natkunam, Y; Berry, G; Bangs, CD; Cherry, A; Dahl, G
    Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    K. Suryanarayan et al., "Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation", J PED H ONC, 23(7), 2001, pp. 452-455
90. Nichols, JC; Ince, A; Akduman, L; Mann, ES
    Interferon-alpha 2a treatment of neuro-Behcet disease
    JOURNAL OF NEURO-OPHTHALMOLOGY
    
    J.C. Nichols et al., "Interferon-alpha 2a treatment of neuro-Behcet disease", J NEURO-OPH, 21(2), 2001, pp. 109-111
91. Preiksaitis, JK; Keay, S
    Diagnosis and management of posttransplant lymphoproliferative disorder insolid-organ transplant recipients
    CLINICAL INFECTIOUS DISEASES
    
    J.K. Preiksaitis e S. Keay, "Diagnosis and management of posttransplant lymphoproliferative disorder insolid-organ transplant recipients", CLIN INF D, 33, 2001, pp. S38-S46
92. Ko, WJ; Chou, NK; Hsu, RB; Chen, YS; Wang, SS; Chu, SH; Lai, MY
    Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    W.J. Ko et al., "Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area", J HEART LUN, 20(8), 2001, pp. 865-875
93. Martinez, EH
    Hepatitis B and hepatitis C co-infection in patients with HIV
    REVIEWS IN MEDICAL VIROLOGY
    
    E.H. Martinez, "Hepatitis B and hepatitis C co-infection in patients with HIV", REV MED VIR, 11(4), 2001, pp. 253-270
94. Witzke, O; Winterhagen, T; Saller, B; Roggenbuck, U; Lehr, I; Philipp, T; Mann, K; Reinhardt, W
    Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2
    THYROID
    
    O. Witzke et al., "Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2", THYROID, 11(7), 2001, pp. 665-670
95. Markou, K; Georgopoulos, N; Kyriazopoulou, V; Vagenakis, AG
    Iodine-induced hypothyroidism
    THYROID
    
    K. Markou et al., "Iodine-induced hypothyroidism", THYROID, 11(5), 2001, pp. 501-510
96. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
    Chronic myelogenous leukemia: Laboratory diagnosis and monitoring
    GENES CHROMOSOMES & CANCER
    
    Y.L. Wang et al., "Chronic myelogenous leukemia: Laboratory diagnosis and monitoring", GENE CHROM, 32(2), 2001, pp. 97-111
97. Chuntharapai, A; Lai, J; Huang, XJ; Gibbs, V; Kim, KJ; Presta, LG; Stewart, TA
    Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: A candidate therapeutic for IDDM and SLE
    CYTOKINE
    
    A. Chuntharapai et al., "Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: A candidate therapeutic for IDDM and SLE", CYTOKINE, 15(5), 2001, pp. 250-260
98. Oshima, K; Yanase, N; Ibukiyama, C; Yamashina, A; Kayagaki, N; Yagita, H; Mizuguchi, J
    Involvement of trail/trail-R interaction in IFN-alpha-induced apoptosis ofdaudi B lymphoma cells
    CYTOKINE
    
    K. Oshima et al., "Involvement of trail/trail-R interaction in IFN-alpha-induced apoptosis ofdaudi B lymphoma cells", CYTOKINE, 14(4), 2001, pp. 193-201
99. Noh, GW; Lee, KY
    Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: Randomizedcase-controlled study
    CYTOKINE
    
    G.W. Noh e K.Y. Lee, "Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: Randomizedcase-controlled study", CYTOKINE, 13(2), 2001, pp. 124-128
100. Airoldi, M; De Stefani, A; Marchionatti, S; Pedani, F; Gabriele, P; Ragona, R; Cortesina, G; Bumma, C
     Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy
     HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
     
     M. Airoldi et al., "Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy", HEAD NECK, 23(4), 2001, pp. 298-304